Codexis (CDXS) Amortization of Deferred Charges (2020 - 2026)
Codexis (CDXS) posted quarterly Amortization of Deferred Charges of $935000.0 for Q1 2026, up 232.74% year-over-year from $281000.0 in Q1 2025, and up 207.1% quarter-over-quarter from -$873000.0 in Q4 2025.
Codexis (CDXS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Codexis' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $935000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 232.74% year-over-year to $935000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 80.72% YoY), while the FY2025 annual figure was $1.3 million, up 47.46% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $935000.0, up from -$873000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $3.6 million in Q3 2023, with the low at -$3.6 million in Q4 2023.
- The 5-year median for Amortization of Deferred Charges is $291000.0 (2025), against an average of $183823.5.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges tumbled 523.65% in 2022, then jumped 242.68% in 2025.
- Codexis' Amortization of Deferred Charges stood at -$3.6 million in 2022, then declined by 0.8% to -$3.6 million in 2023, then jumped by 59.45% to -$1.5 million in 2024, then surged by 40.97% to -$873000.0 in 2025, then surged by 207.1% to $935000.0 in 2026.
- Business Quant data shows CDXS's Amortization of Deferred Charges at $935000.0 in Q1 2026, -$873000.0 in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 947,000.00 |
| Jun 30, 2026 | 947,000.00 |
| Mar 31, 2026 | 935,000.00 |
| Mar 31, 2026 | 935,000.00 |
| Dec 31, 2025 | -873,000.00 |
| Dec 31, 2025 | -873,000.00 |
| Sep 30, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 291,000.00 |
| Mar 31, 2025 | 281,000.00 |
| Mar 31, 2025 | 281,000.00 |
| Dec 31, 2024 | -1.48 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 263,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Mar 31, 2024 | 82,000.00 |